Related by context. All words. (Click for frequent words.) 66 MAGE A3 ASCI 66 receptor tyrosine kinase inhibitor 66 MGd 64 galiximab 64 Gleevec resistant 64 thalidomide Thalomid 64 YONDELIS 64 relapsed MM 64 recurrent glioblastoma multiforme 64 Degarelix 64 Cloretazine 64 sorafenib Nexavar 64 Evoltra ® 63 Aplidin 63 GRN# 63 SNT MC# 63 IMA# 63 neoadjuvant treatment 63 immune modulating 63 huN# DM1 63 Fludara ® 63 Velcade bortezomib 63 trastuzumab Herceptin ® 63 ganetespib 63 adalimumab Humira 63 refractory ovarian cancer 63 Kantarjian 63 cyclophosphamide chemotherapy 63 ruxolitinib 63 Rituxan rituximab 63 humanised monoclonal antibody 63 Bezielle 63 trastuzumab DM1 63 oral prodrug 62 antiangiogenic therapy 62 triphendiol 62 ixabepilone 62 omega interferon 62 CD# antibody [001] 62 malignant ascites 62 dasatinib Sprycel 62 ELACYT 62 octreotide 62 refractory prostate cancer 62 Tarceva TM 62 Zybrestat 62 palifermin 62 MYLOTARG 62 ZACTIMA 62 metastatic malignant melanoma 62 Octreotide 62 Xanafide 62 PNP inhibitor 62 Ceflatonin 62 AKT inhibitor 62 adjuvant colon cancer 62 mRCC 62 Nexavar sorafenib 62 refractory colorectal cancer 62 relapsed multiple myeloma 62 Pazopanib 62 diabetic neuropathic pain 62 alvespimycin 62 taxane refractory 62 imatinib Gleevec 62 dexamethasone Decadron 62 estramustine 62 budesonide foam 62 Aflibercept 62 Peginterferon alfa 2b 61 Mitoxantrone 61 HGS# 61 antitumor effect 61 Phase Ib study 61 noninfectious uveitis 61 refractory NSCLC 61 TTF Therapy 61 endocrine therapies 61 radiation sensitizer 61 heavily pretreated 61 Triapine R 61 superficial bladder cancer 61 Eribulin 61 acetonide FA 61 demonstrated antitumor activity 61 oxypurinol 61 selective modulator 61 Sutent sunitinib 61 dasatinib Sprycel ® 61 esophageal candidiasis 61 tanespimycin 61 Noxafil 61 biliary tract cancer 61 cediranib 61 mitoxantrone plus 61 gastrointestinal stromal tumors GIST 61 Factor VIIa 61 rituximab Rituxan 61 capecitabine Xeloda 61 CTAP# Capsules 61 Pemetrexed 61 alkylating agent 61 riociguat 61 OMNARIS HFA 61 Gleevec imatinib 61 therapeutic regimens 61 nalbuphine ER 61 urocortin 2 61 erlotinib Tarceva ® 61 Darinaparsin 61 myelodysplastic myeloproliferative diseases 61 generation purine nucleoside 61 FTY# fingolimod 61 prostate cancer mCRPC 61 piperacillin tazobactam 61 Neoadjuvant 61 Pharmacokinetics PK 61 Soliris TM eculizumab 61 NP2 Enkephalin 61 recurrent glioblastoma 61 preclinically 61 Alocrest 61 Revlimid lenalidomide 61 RhuDex ® 61 chemoradiotherapy 61 denileukin diftitox 61 PKC# 61 OvaRex ® MAb 61 Panzem R 61 pomalidomide 61 Omacetaxine 60 paclitaxel poliglumex 60 dexanabinol 60 tubulin inhibitor 60 TEMODAL 60 depsipeptide 60 ara C 60 Gemzar gemcitabine 60 KRN# 60 anthracyclines taxanes 60 Genasense ® 60 Zingo TM 60 colorectal cancer liver metastases 60 refractory CLL 60 OHR/AVR# 60 basiliximab 60 Bortezomib 60 lymphoid malignancies 60 gemtuzumab ozogamicin 60 chemopreventive agent 60 TroVax ® 60 cetuximab Erbitux ® 60 Sudhir Agrawal D.Phil 60 neoadjuvant chemotherapy 60 amrubicin 60 metastatic malignant 60 imatinib Gleevec ® 60 etanercept Enbrel 60 VNP#M 60 refractory myeloma 60 paclitaxel Taxol R 60 vidofludimus 60 cell lymphoma CTCL 60 BRAF inhibitor 60 lenalidomide dexamethasone 60 vemurafenib 60 gemcitabine carboplatin 60 indolent NHL 60 investigational therapies 60 Cloretazine ® 60 bortezomib Velcade R 60 cisplatin chemotherapy 60 mapatumumab 60 trabectedin 60 goserelin 60 cilengitide 60 imatinib therapy 60 bosutinib 60 EndoTAGTM 1 60 histamine dihydrochloride 60 pertuzumab 60 PEGylated Fab fragment 60 refractory cutaneous T 60 Pradefovir 60 BCG refractory 60 forodesine 60 Bendamustine 60 Kepivance 60 baminercept 60 polycythemia vera essential thrombocythemia 60 axitinib 60 CA9 SCAN 60 Proxinium TM 60 FluCide 60 Doxil ® 60 HQK 60 apremilast 60 panobinostat 60 HER2 positive metastatic breast 60 alfa 2a 60 perioperatively 60 tumors GIST 60 intranasal formulation 60 eribulin mesylate 60 metastatic renal cell carcinoma 60 enzastaurin 60 docetaxel Taxotere ® 60 adjuvant cisplatin 60 SUPPRELIN R LA 60 bortezomib Velcade 60 oral methylnaltrexone 60 phase IIb trial 60 PDE4 inhibitor 60 interferon alfa 2b 60 Femara letrozole 60 blood clot dissolving 60 HSP# inhibitor 60 leukemia AML 60 haematological cancers 60 interferon ribavirin 60 non splenectomized 60 Irinotecan 60 RSD# oral 60 targeted antifolate 60 IRX 2 60 MP4OX 60 miconazole Lauriad ® 60 pamidronate 60 subcutaneous methylnaltrexone 60 adjuvant radiotherapy 60 concurrent chemoradiation 60 ISTODAX 60 haematological malignancies 60 intra arterial chemotherapy 60 paclitaxel Taxol ® 60 DDP# 60 immunomodulatory therapy 60 antiangiogenesis 60 colorectal liver metastases 60 hepatorenal syndrome 60 cinacalcet 59 relapsed ovarian cancer 59 tremelimumab 59 Arzerra ofatumumab 59 bendamustine 59 novel oral anticoagulant 59 Virulizin ® 59 TRISENOX 59 prucalopride 59 PrevOnco 59 Campath alemtuzumab 59 dose escalation phase 59 thetreatment 59 Herceptin trastuzumab 59 hepatic metastases 59 cinacalcet HCl 59 cetuximab Erbitux R 59 p# inhibitor 59 Ophena TM 59 liposomal formulation 59 monoclonal antibody conjugated 59 decitabine 59 Capesaris 59 sodium stibogluconate 59 huC# DM4 59 everolimus tablets 59 dacetuzumab 59 Lubiprostone 59 unresectable tumors 59 cariprazine 59 FUSILEV enhances 59 Vicinium TM 59 neratinib 59 cMET 59 Certolizumab pegol 59 OMP #M# 59 erlotinib Tarceva 59 CYT# potent vascular disrupting 59 somatostatin analogues 59 5-fluorouracil/leucovorin 59 Panzem R NCD 59 heavily pretreated patients 59 DFMO 59 Neulasta ® 59 LHRH receptor positive 59 Erlotinib 59 fulvestrant 59 docetaxel chemotherapy 59 IV Busulfex 59 mertansine 59 eniluracil 59 bevacizumab Avastin ® 59 Annamycin 59 CLL SLL 59 prokinetic agent 59 platelet inhibitor 59 cytoreduction 59 refractory AML 59 HuMax CD4 59 rufinamide 59 p# MAP kinase inhibitor 59 gemcitabine cisplatin 59 Cancidas 59 agomelatine 59 IL# PE#QQR 59 topical ocular 59 acute mania 59 refractory acute myeloid 59 Vidofludimus 59 phase Ib 59 immune modulatory 59 Myelodysplastic Syndrome MDS 59 Azacitidine 59 teriflunomide 59 Kamada AAT 59 antifibrotic 59 elotuzumab 59 PI3K/Akt pathway inhibitor 59 afamelanotide 59 Vandetanib 59 ritonavir boosted 59 Targretin capsules 59 basal cell carcinoma BCC 59 ponatinib 59 eosinophilic asthma 59 mecasermin 59 CINTREDEKIN BESUDOTOX 59 Aloxi injection 59 Allovectin 7 ® 59 taxane resistant 59 hormone refractory 59 oral picoplatin 59 peripherally acting 59 Cimzia TM 59 PDE# inhibitors 59 VA# [002] 59 eltrombopag 59 EOquin TM 59 mu opioid receptor antagonist 59 Troxatyl 59 lumiliximab 59 Aclidinium 59 metastatic colorectal 59 pegylated liposomal doxorubicin 59 temsirolimus 59 ATL/TV# 59 herpetic keratitis 59 cannabinor 59 gemcitabine Gemzar ® 59 tolerability profiles 59 Erbitux cetuximab 59 KRAS mutant tumors 59 oral beclomethasone dipropionate 59 IMGN# 59 ACTEMRA TM 59 torsemide ER 59 Fludara 59 Flu Cy 59 aflibercept VEGF Trap 59 remission induction 59 Melphalan 59 VAPRISOL 59 Elacytarabine 59 antibody MAb 59 mTOR inhibition 59 oral antiviral 59 IMC A# 59 Removab 59 trastuzumab Herceptin R 59 targeted radiotherapeutic 59 anti angiogenic agents 59 AEG# 59 elacytarabine 59 romidepsin 59 dose melphalan 59 Taxotere chemotherapy 59 essential thrombocythemia ET 59 phase IIb clinical 59 metastatic gastric 59 oral rivaroxaban 59 docetaxel Taxotere 59 urothelial bladder cancer 59 Vidaza azacitidine 59 Natalizumab 59 azacitidine 59 Telintra 59 Alessandro Riva 59 Phase #b/#a clinical 59 fluoropyrimidine 58 pegfilgrastim 58 refractory chronic lymphocytic 58 Trastuzumab 58 relapsed refractory multiple myeloma 58 luteinizing hormone releasing 58 metastatic bladder 58 lorvotuzumab mertansine 58 pain palliation 58 LHRH analogues 58 liposomal amphotericin B 58 sorafenib Nexavar ® 58 ocular formulation 58 Xeloda ® 58 trastuzumab Herceptin 58 CYT# 58 nucleotide analog 58 vapreotide acetate 58 ulimorelin 58 Amrubicin 58 temozolomide Temodar 58 HERCEPTIN 58 INTEGRILIN ® 58 IGF 1R inhibitor 58 T#I [002] 58 radiotherapy RT 58 Urocidin 58 Dacogen decitabine 58 vinflunine 58 MDS AML 58 methylnaltrexone 58 Granulocyte Colony Stimulating Factor 58 Pertuzumab 58 smoldering multiple myeloma 58 nicardipine 58 neoadjuvant setting 58 Epratuzumab 58 IIa trial 58 KIACTA ™ 58 prostate cancer CRPC 58 BrachySil 58 pharmacokinetic interactions 58 ZOLINZA 58 BZL# 58 AQ4N 58 recurrent GBM 58 immune modulator 58 ThGRF 58 EOquin 58 PROCHYMAL 58 Gleevec Glivec 58 Aviptadil 58 Hycamtin 58 BCR ABL inhibitor 58 regorafenib 58 Phase IIb clinical trials 58 MGN# 58 DepoDur 58 beta 1a 58 Cell Lymphoma CTCL 58 sorafenib tablets 58 Adjuvant chemotherapy 58 antifungal therapy 58 Belldegrun 58 reteplase 58 Pseudomonas aeruginosa infections 58 Insegia 58 Chemophase 58 EGFR inhibitors 58 rhGH 58 Glioblastoma Multiforme 58 BAY #-# 58 metastatic HRPC 58 samalizumab 58 SYN# 58 de novo AML 58 ganciclovir 58 Gefitinib 58 dalbavancin 58 motesanib 58 phase IIa clinical 58 conventional DMARDs 58 relapsed refractory 58 EGFR TKI 58 inhalation powder 58 treating neuropathic pain 58 Pyridorin 58 multitargeted 58 Pathway Inhibitor 58 Phase Ib clinical 58 antimetabolite 58 iniparib 58 treat chronic sinusitis 58 PXD# 58 HGS ETR2 58 Vaprisol 58 TBC# 58 alefacept 58 Prosaptide 58 PEG IFN 58 Solasia 58 recurrent herpes labialis 58 gastrointestinal stromal tumor GIST 58 TOCOSOL Camptothecin 58 chemoradiation therapy 58 cutaneous T 58 silodosin 58 TKM ApoB 58 postoperative chemotherapy 58 CA4P 58 Personalized Immunotherapy 58 Torisel 58 Valdoxan 58 YONDELIS R 58 mycophenolate mofetil 58 vinorelbine tartrate 58 adjuvant therapy 58 PhG alpha 1 58 Tamibarotene 58 EGFR expressing mCRC 58 immunomodulator 58 hA# 58 Zemplar Capsules 58 AEGR 58 taxane chemotherapy 58 postsurgical pain 58 CCR9 antagonist 58 verteporfin 58 Fibrillex TM 58 CIMZIA TM 58 subcutaneous formulation 58 CIMZIA R 58 advanced metastatic renal 58 efalizumab 58 evaluating tivozanib 58 BNC# 58 relapsing multiple sclerosis 58 vinca alkaloid 58 anthracycline taxane 58 antiangiogenic 58 Afatinib 58 Evoltra TM 58 Tasimelteon 58 Apoptone 58 CytoFabTM 58 relapsed acute myelogenous 58 palliative radiotherapy 58 Carfilzomib 58 PRT# 58 VEGF receptor inhibitor 58 Arranon 58 invasive candidiasis 58 CELVAPAN H#N# 58 gepirone ER 58 zalutumumab 58 peritoneal carcinomatosis 58 JAK inhibitors 58 TG# [003] 58 uric acid lowering 58 isoform selective 58 pancreatic adenocarcinoma 58 castrate resistant prostate cancer 58 CANCIDAS 58 ziconotide 58 xenograft models 58 receptor inhibitor 58 advanced carcinoid 58 metastatic uveal melanoma 58 oblimersen 58 Vojo Vukovic MD Ph.D. 58 anti leukemic 58 paclitaxel cisplatin 58 metastatic GIST 58 LHRH antagonist 58 plasma kallikrein inhibitor 58 platinum refractory 58 BCR ABL inhibitors 58 treatmentof 58 Mipomersen 58 imatinib resistant 58 Imprime PGG 58 clevidipine 58 Dasatinib 58 AGILECT R 58 relapsed leukemia 58 AGHD 58 liposomal doxorubicin 58 INCB# [001] 58 methotrexate therapy 58 mTOR inhibitors 58 TKI therapy 58 TYZEKA 58 metastatic kidney 58 weekly subcutaneous injections 58 pemphigus vulgaris 58 refractory indolent non 58 microtubule inhibitor 58 alpha 2a 58 CHOP chemotherapy 58 HuMax CD# 58 Glivec imatinib 58 Pegasys peginterferon alfa 2a 58 apoptosis inducer 58 Anidulafungin 58 PSMA ADC 58 dual orexin receptor 57 myeloid metaplasia 57 Simulect 57 vorinostat 57 APTIVUS r 57 pradefovir 57 PROMACTA 57 EVIZON TM 57 systemic fungal infections 57 LHRH agonists 57 lymphoma CTCL 57 ® lenalidomide 57 multiple myeloma MM 57 recurrent NSCLC 57 systemic antifungal 57 receiving highly emetogenic 57 REMUNE R 57 neurotrophic 57 prokinetic 57 multi kinase inhibitor 57 Zavesca R 57 EndoTAG TM -1 57 Omnitarg 57 LHRH 57 Valproic acid 57 ribavirin RBV 57 phase III isavuconazole 57 overactive bladder syndrome 57 docetaxel Taxotere R 57 taxotere 57 OvaRex R 57 previously untreated follicular 57 ORENCIA R 57 refractory chronic myeloid 57 TLR9 agonist 57 reslizumab 57 transplantation HSCT 57 Taxotere docetaxel 57 zileuton 57 EGFRIs 57 sargramostim 57 investigational monoclonal antibody 57 antithrombotic 57 antiresorptive 57 HIV coinfected 57 taxane chemotherapy administered 57 SPRYCEL ® 57 BioNumerik 57 rolapitant 57 Zenvia ™ 57 calcineurin inhibitor 57 infusional 5-FU/LV 57 corticosteroid dexamethasone 57 sunitinib malate 57 Archexin 57 somatostatin analogue 57 volociximab 57 Everolimus 57 Platinol ® cisplatin 57 Prodarsan ® 57 molecular remissions 57 cisplatin gemcitabine 57 Perforomist ™ Inhalation Solution 57 standard chemotherapy regimens 57 corticosteroids immunoglobulins 57 tafamidis 57 panitumumab Vectibix 57 idiopathic thrombocytopenic purpura 57 EGFR tyrosine kinase inhibitors 57 vandetanib 57 Lenalidomide 57 operable breast cancer 57 lenalidomide Revlimid 57 Temodar ® 57 surgical debulking 57 Belatacept 57 fallopian tube cancers 57 idiopathic thrombocytopenic purpura ITP 57 Sprycel dasatinib 57 refractory CTCL 57 miglustat 57 Temsirolimus 57 chemotherapy cisplatin 57 hypoxia activated prodrug 57 Darusentan 57 EVIZON ™ 57 differentiated thyroid 57 Cytoxan 57 Xyfid TM 57 AMEVIVE 57 hypereosinophilic syndrome 57 farletuzumab 57 micafungin 57 TELINTRA 57 sorafenib Nexavar R 57 anti amnesic 57 QVAR 57 Anavex #-# 57 assessing T DM1 57 rhIGF-I/rhIGFBP-3 57 Squalamine 57 Luteinizing Hormone Releasing Hormone 57 Increlex R 57 Phase IIIb clinical 57 PROSTVAC ® 57 diabetic gastroparesis 57 secondary hyperparathyroidism 57 hormone LHRH antagonist 57 anti angiogenic therapy 57 Combidex 57 neoadjuvant therapy 57 acyclovir Lauriad R 57 AQUAVAN R 57 Alvesco R 57 cytoprotective 57 allogeneic HSCT 57 abatacept Orencia 57 tezampanel 57 carcinoid tumors 57 Romiplostim 57 PrevOnco ™ 57 dose dexamethasone 57 immuno modulatory 57 HIPEC 57 factor TNF 57 Vascugel 57 LEUKINE 57 allogeneic hematopoietic stem cell 57 systemic ALCL 57 Traficet EN 57 systemic hypotension 57 Onrigin 57 proteasome inhibitor 57 Toxicities 57 octreotide implant 57 systemic anaplastic large 57 cytotoxic therapy 57 Cloretazine R 57 IMiDs ® 57 incyclinide 57 histone deacetylase HDAC inhibitor 57 GnRH antagonist 57 VEGF inhibitors 57 doxorubicin cyclophosphamide 57 microwave hyperthermia 57 TNF alpha inhibitor 57 posaconazole 57 gefitinib Iressa 57 Gleevec imatinib mesylate 57 lintuzumab SGN 57 bacillus Calmette Guerin 57 Panzem 57 FOLFOX6 57 RH1 57 oral ridaforolimus 57 epirubicin 57 capecitabine Xeloda R 57 BEXXAR 57 rindopepimut 57 Gliadel Wafer 57 AAG geldanamycin analog 57 follicular NHL 57 hepatic fibrosis 57 irinotecan chemotherapy 57 FSAD 57 xanthine oxidase inhibitor 57 castration resistant prostate cancer 57 LEP ETU 57 relapsed ALL 57 metastatic CRC 57 2 methoxyestradiol 57 lurasidone 57 refractory metastatic 57 Silodosin 57 medically refractory 57 nucleoside analog 57 radiotherapeutic 57 CML CP 57 melphalan prednisone 57 MNTX 57 Fenretinide 57 renal tumors 57 Zoraxel 57 Preclinical studies suggest 57 Bevacizumab Avastin 57 ganaxolone 57 catheter occlusion 57 Proquin XR 57 anti tubercular 57 IV NSCLC 57 MyVax 57 rheumatoid arthritis psoriatic arthritis 57 grade cervical intraepithelial 57 5 fluorouracil leucovorin 57 refractory Hodgkin lymphoma 57 cidofovir 57 Leukine ® 57 Zavesca r 57 IIa trials 57 painful diabetic neuropathy 57 mg/m2 dose 57 Gel repository corticotropin injection 57 Dacogen injection 57 MOVIPREP R 57 protease inhibitor PI 57 isavuconazole 57 Hsp# Inhibitor 57 Surgical resection 57 biologic therapy 57 oral deforolimus 57 ovarian carcinoma 57 Akt inhibitor 57 daunorubicin 57 gemcitabine chemotherapy 57 visilizumab 57 adefovir dipivoxil 57 echinocandin 57 Torisel temsirolimus 57 relapsed myeloma 57 terlipressin 57 Fludarabine 57 antiangiogenic agents 57 topical formulation 57 SIR Spheres 57 lenalidomide Revlimid R 57 oral anti arrhythmic 57 hematological indications 57 abacavir Ziagen 57 Alinia 57 Allovectin 7 57 ARIKACE ™ 56 G CSF 56 Xelox 56 #D#C# 56 argatroban 56 lymphocytosis 56 Ixempra 56 diarrhea predominant irritable 56 Raptiva ® 56 opioid induced constipation OIC 56 OncoGel 56 cytotoxic therapies 56 K ras mutations 56 IAP inhibitor 56 Provecta 56 oxymorphone ER 56 omacetaxine mepesuccinate 56 albumin bound paclitaxel 56 T DM1 56 allogeneic bone marrow 56 octreotide acetate 56 Advagraf 56 sunitinib Sutent ® 56 PS# DARA 56 lamivudine refractory patients 56 EVIZON 56 adecatumumab 56 doxorubicin docetaxel 56 dacarbazine DTIC 56 CD3 monoclonal antibody 56 cathepsin K inhibitor 56 recurrent metastatic 56 immunosuppressant drug 56 stage IIIb 56 adriamycin 56 hematopoietic cancers 56 acromegalic patients 56 Saforis 56 Intravenous immunoglobulin 56 nilotinib Tasigna ® 56 Orphan Drug status 56 carcinoid syndrome 56 lymphomas leukemias 56 Prestara 56 Alimta pemetrexed 56 Zarnestra 56 MyVax R 56 Cinryze ™ 56 pharmacologic intervention 56 RRMS patients 56 NEUMUNE 56 Sanvar R 56 desvenlafaxine succinate 56 Cannabinor 56 myeloablative 56 liver resection 56 gastric adenocarcinoma 56 IV bisphosphonates 56 Yondelis ® 56 SUTENT 56 oropharyngeal candidiasis OPC 56 trastuzumab DM1 T DM1 56 acute GvHD 56 Anthracycline 56 nilotinib 56 anticancer therapy 56 genotypic resistance 56 Tarceva erlotinib 56 Pimavanserin 56 nosocomial pneumonia 56 chemotherapy docetaxel 56 Increlex ® 56 polycythemia vera PV 56 nucleoside analogs 56 plus dexamethasone 56 cabazitaxel 56 severe gastroparesis 56 amphotericin B 56 tipranavir 56 induced macular edema 56 myeloproliferative disorders 56 caspofungin 56 Abiraterone acetate 56 radiolabeled TM# 56 ESBA# 56 DCVax ® Brain 56 Laquinimod 56 LE DT 56 Sym# 56 IV melanoma 56 PREZISTA r 56 GW# [003] 56 SinuNase ™ 56 DACH platinum 56 non resectable 56 Dyloject TM 56 BRAF V# mutation 56 Methylnaltrexone 56 Bicifadine 56 hyperphenylalaninemia HPA due 56 favorable pharmacokinetic 56 receptor blocker 56 Etoposide 56 refractory gout 56 rilonacept 56 stem cell engraftment 56 BARACLUDE ® 56 Copegus ribavirin 56 itraconazole 56 Quinamed 56 humanized anti 56 idarubicin 56 mCRC patients 56 plus prednisone prednisolone 56 MyVax personalized immunotherapy 56 candidemia 56 SCENESSE ® 56 clofarabine 56 lung fibrosis 56 Phase IIb trials 56 dextromethorphan quinidine 56 grade cervical dysplasia 56 KRAS mutations occur 56 superficial basal cell carcinoma 56 nab paclitaxel 56 pimecrolimus 56 bronchodilatory 56 TREANDA 56 RSR# 56 Zolinza 56 Taxol paclitaxel 56 dasatinib 56 hypomethylating agents 56 mTOR inhibitor 56 vismodegib 56 bleomycin 56 inhaled iloprost 56 prostate carcinoma 56 Dextofisopam 56 tuberous sclerosis TS 56 anidulafungin 56 autologous hematopoietic stem cell 56 MOZOBIL 56 epithelial tumors 56 UPLYSO 56 immunosuppressive therapies 56 radioiodine therapy 56 relapsing remitting MS RRMS 56 cyclophosphamide Cytoxan 56 Azedra 56 TheraCIM 56 BEMA TM LA 56 GALNS 56 Marqibo 56 complete remissions 56 imatinib mesylate 56 MetMAb 56 hematological cancers 56 intravenous cyclophosphamide 56 Cleviprex TM clevidipine 56 thrombolytic agent 56 radiochemotherapy 56 HER2 overexpression 56 MyVax ® 56 tumor necrosis 56 metastatic RCC 56 commercialize deforolimus 56 Ixabepilone 56 MCyR 56 phase IIb study 56 uterine fibroid 56 OncoVEX GM CSF 56 HER2 positive cancers 56 chemotherapy induced neutropenia 56 rasagiline tablets 56 recurrent malignant glioma